BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12135291)

  • 1. Overexpression of vascular endothelial growth factor and its endothelial cell receptor KDR in type 1 leprosy reaction.
    Fiallo P; Clapasson A; Favre A; Pesce C
    Am J Trop Med Hyg; 2002 Feb; 66(2):180-5. PubMed ID: 12135291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat.
    Ogata N; Yamanaka R; Yamamoto C; Miyashiro M; Kimoto T; Takahashi K; Maruyama K; Uyama M
    Curr Eye Res; 1998 Nov; 17(11):1087-96. PubMed ID: 9846628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
    Bogic LV; Brace RA; Cheung CY
    Placenta; 2001 Apr; 22(4):265-75. PubMed ID: 11286562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of vascular endothelial growth factor and its receptor flt-1 in malignant pleural mesothelioma.
    König J; Tolnay E; Wiethege T; Müller K
    Respiration; 2000; 67(1):36-40. PubMed ID: 10705260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis.
    Horita Y; Miyazaki M; Koji T; Kobayashi N; Shibuya M; Razzaque MS; Cheng M; Ozono Y; Kohno S; Taguchi T
    Nephrol Dial Transplant; 1998 Oct; 13(10):2519-28. PubMed ID: 9794554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
    J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
    Hatva E; Böhling T; Jääskeläinen J; Persico MG; Haltia M; Alitalo K
    Am J Pathol; 1996 Mar; 148(3):763-75. PubMed ID: 8774132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.
    Simon M; Gröne HJ; Jöhren O; Kullmer J; Plate KH; Risau W; Fuchs E
    Am J Physiol; 1995 Feb; 268(2 Pt 2):F240-50. PubMed ID: 7864162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and its receptors.
    Neufeld G; Tessler S; Gitay-Goren H; Cohen T; Levi BZ
    Prog Growth Factor Res; 1994; 5(1):89-97. PubMed ID: 7515293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
    Straume O; Akslen LA
    Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.
    Rissanen TT; Vajanto I; Hiltunen MO; Rutanen J; Kettunen MI; Niemi M; Leppänen P; Turunen MP; Markkanen JE; Arve K; Alhava E; Kauppinen RA; Ylä-Herttuala S
    Am J Pathol; 2002 Apr; 160(4):1393-403. PubMed ID: 11943724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the immunohistochemical distribution patterns of vascular endothelial growth factor receptors Flk1 and Flt1 in bleomycin-induced rat lung fibrosis.
    Fehrenbach H; Haase M; Kasper M; Koslowski R; Schuh D; Müller M
    Virchows Arch; 1999 Jul; 435(1):20-31. PubMed ID: 10431842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF and flt. Expression time kinetics in rat brain infarct.
    Kovács Z; Ikezaki K; Samoto K; Inamura T; Fukui M
    Stroke; 1996 Oct; 27(10):1865-72; discussion 1872-3. PubMed ID: 8841346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E; Schatteman G; Wu T; Kim EA; Varticovski L; Keyt B; Isner JM
    J Clin Invest; 1996 Jan; 97(2):469-76. PubMed ID: 8567969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells.
    Wang DS; Miura M; Demura H; Sato K
    Endocrinology; 1997 Jul; 138(7):2953-62. PubMed ID: 9202240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.